Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Synergistic and opposing regulation of the stress-responsive gene IEX-1 by p53, c-Myc, and multiple NF-κB/rel complexes

Abstract

NF-κB/rel proteins, tumor suppressor p53, and oncogene c-Myc are critical transcription factors involved in coordinating cellular decision-making events in response to external stimuli. Consensus sequences for binding these three transcription factors are found in the promoter region of IEX-1 (Immediate Early response gene X-1) gene that can either suppress or induce apoptosis in a cell- and stimulus-dependent manner. Utilizing an electrophoretic mobility shift assay (EMSA) and a promoter/reporter assay, we show that the NF-κB/rel consensus sequence in the IEX-1 promoter is specifically bound and activated by multiple NF-κB/rel complexes in descending order p65-c-rel→p65–50→p50–50. Interestingly, NF-κB/rel-mediated activation of IEX-1 expression was synergized by p53, but strongly inhibited by c-Myc in a dose-dependent fashion. Moreover, the ability of c-Myc to inhibit IEX-1 expression requires the presence of functional p53, which may partially contribute to the varying effects of p53 on IEX-1 expression in different cells. In support of coordinated regulation of IEX-1 expression by these three transcription factors in vivo, binding of endogenous p53, c-Myc and NF-κB/rel proteins, including p50, p65 and c-rel, to the IEX-1 promoter was demonstrated in living cells by chromatin immunoprecipitation using specific antibodies. The study reveals a novel integrative regulation of specific gene expression by NF-κB/rel, p53 and c-Myc transcription factors.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  • Arlt A, Grobe O, Sieke A, Kruse ML, Folsch UR, Schmidt WE, Schafer H . 2001 Oncogene 20: 69–76

  • Baeuerle PA, Baltimore D . 1996 Cell 87: 13–20

  • Bates S, Vousden KH . 1999 Cell Mol. Life Sci. 55: 28–37

  • Beg AA, Baldwin Jr AS . 1993 Genes Dev. 7: 2064–2070

  • Beg AA, Baltimore D . 1996 Science 274: 782–784

  • Beg AA, Sha WC, Bronson RT, Ghosh S, Baltimore D . 1995 Nature 376: 167–170

  • Benoit V, Hellin AC, Huygen S, Gielen J, Bours V, Merville MP . 2000 Oncogene 19: 4787–4794

  • Blackwell TK, Kretzner L, Blackwood EM, Eisenman RN, Weintraub H . 1990 Science 250: 1149–1151

  • Boyd KE, Farnham PJ . 1999 Mol. Cell Biol. 19: 8393–8399

  • Ceballos E, Delgado MD, Gutierrez P, Richard C, Muller D, Eilers M, Ehinger M, Gullberg U, Leon J . 2000 Oncogene 19: 2194–2204

  • Charles CH, Yoon JK, Simske JS, Lau LF . 1993 Oncogene 8: 797–801

  • Dignam JD, Lebovitz RM, Roeder RG . 1983 Nucleic Acids Res. 11: 1475–1489

  • Domachowske JB, Bonville CA, Mortelliti AJ, Colella CB, Kim U, Rosenberg HF . 2000 J. Infect. Dis. 181: 824–830

  • El Deiry WS, Kern SE, Pietenpol JA, Kinzler KW, Vogelstein B . 1992 Nat. Genet. 1: 45–49

  • Evan GI, Wyllie AH, Gilbert CS, Littlewood TD, Land H, Brooks M, Waters CM, Penn LZ, Hancock DC . 1992 Cell 69: 119–128

  • Feldmann KA, Pittelkow MR, Roche PC, Kumar R, Grande JP . 2001 Histochem. Cell Biol. 115: 489–497

  • Grilli M, Chiu JJ, Lenardo MJ . 1993 Int. Rev. Cytol. 143: 1–62

  • Grobe O, Arlt A, Ungefroren H, Krupp G, Folsch UR, Schmidt WE, Schafer H . 2001 FEBS Lett. 494: 196–200

  • Henriksson M, Luscher B . 1996 Adv. Cancer Res. 68: 109–182

  • Hermeking H, Eick D . 1994 Science 265: 2091–2093

  • Ikeda A, Sun X, Li Y, Zhang Y, Eckner R, Doi TS, Takahashi T, Obata Y, Yoshioka K, Yamamoto K . 2000 Biochem. Biophys. Res. Commun. 272: 375–379

  • Im HJ, Pittelkow MR, Kumar R . 2002 J. Biol. Chem. 277: 14612–14621

  • Jung M, Zhang Y, Dimtchev A, Dritschilo A . 1998 Radiat. Res. 149: 596–601

  • Kawai H, Yamada Y, Tatsuka M, Niwa O, Yamamoto K, Suzuki F . 1999 Cancer Res. 59: 6038–6041

  • Kobayashi T, Pittelkow MR, Warner GM, Squillace KA, Kumar R . 1998 Biochem. Biophys. Res. Commun. 251: 868–873

  • Kondratyev AD, Chung KN, Jung MO . 1996 Cancer Res. 56: 1498–1502

  • Kontgen F, Grumont RJ, Strasser A, Metcalf D, Li R, Tarlinton D, Gerondakis S . 1995 Genes Dev. 9: 1965–1977

  • Kumar R, Kobayashi T, Warner GM, Wu Y, Salisbury JL, Lingle W, Pittelkow MR . 1998 Biochem. Biophys. Res. Commun. 253: 336–341

  • Lane DP . 1993 Nature 362: 786–787

  • Parry GC, Mackman N . 1994 J. Biol. Chem. 269: 20823–20825

  • Pietzsch A, Buchler C, Schmitz G . 1998 Biochem. Biophys. Res. Commun. 245: 651–657

  • Prendergast GC . 1999 Oncogene 18: 2967–2987

  • Ravi R, Mookerjee B, van Hensbergern Y, Bedi GC, Giordano A, El Deiry WS, Fuchs EJ, Bedi A . 1998 Cancer Res. 58: 4531–4536

  • Sala A, Casella I, Grasso L, Bellon T, Reed JC, Miyashita T, Peschle C . 1996 Cancer Res. 56: 1991–1996

  • Schafer H, Diebel J, Arlt A, Trauzold A, Schmidt WE . 1998a FEBS Lett. 436: 139–143

  • Schafer H, Lettau P, Trauzold A, Banasch M, Schmidt WE . 1999 Pancreas 18: 378–384

  • Schafer H, Trauzold A, Sebens T, Deppert W, Folsch UR, Schmidt WE . 1998b Oncogene 16: 2479–2487

  • Schilling D, Pittelkow MR, Kumar R . 2001 Oncogene 20: 7992–7997

  • Segev D, Ha TU, Tran TT, Kenneally M, Harkin P, Jung M, MacLaughlin DT, Donahoe PK, Maheswaran S . 2000 J. Biol. Chem. 275: 28371–28379

  • Sha WC, Liou HC, Tuomanen EI, Baltimore D . 1995 Cell 80: 321–330

  • Thompson EB . 1998 Annu. Rev. Physiol. 60: 575–600

  • Urban MB, Schreck R, Baeuerle PA . 1991 EMBO J. 10: 1817–1825

  • Van Antwerp DJ, Martin SJ, Kafri T, Green DR, Verma IM . 1996 Science 274: 787–789

  • Verma IM, Stevenson JK, Schwarz EM, Van Antwerp D, Miyamoto S . 1995 Genes Dev. 9: 2723–2735

  • Vogelstein B, Kinzler KW . 1992 Cell 70: 523–526

  • Wadgaonkar R, Phelps KM, Haque Z, Williams AJ, Silverman ES, Collins T . 1999 J. Biol. Chem. 274: 1879–1882

  • Webster GA, Perkins ND . 1999 Mol. Cell. Biol. 19: 3485–3495

  • Wu MX, Ao Z, Prasad KV, Wu R, Schlossman SF . 1998 Science 281: 998–1001

  • Yeh WC, Shahinian A, Speiser D, Kraunus J, Billia F, Wakeham A, De la Pompa JL, Ferrick D, Hum B, Iscove N, Ohashi P, Rothe M, Goeddel DV, Mak TW . 1997 Immunity 7: 715–725

  • Zhang Y, Schlossman SF, Edwards RA, Ou CN, Gu J, Wu MX . 2002 Proc. Natl. Acad. Sci. USA 99: 878–883

Download references

Acknowledgements

We thank Drs D Baltimore, A Hoffman and M Scott for p65KO3T3 cells (RelA−/− MEF) and plasmid pGD-RelA, Tse-Hua Tan for p50 and c-rel constructs, and X-H Feng for a c-Myc construct. We are grateful to Dr Peggy J Farnham for sharing his ChIP protocol and to Drs Milton Finegold, Robert A Edwards and Li-Yuan Yu-Lee for critical reading of this manuscript. This work was supported by National Institutes of Health grant AI45003, Research Scholar Grant RSG-01-178-01-MGO from the American Cancer Society, and a Moran foundation award (PRJ 00-109) from Baylor College Medicine (to MX Wu).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jim Yujin Wu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Huang, YH., Wu, J., Zhang, Y. et al. Synergistic and opposing regulation of the stress-responsive gene IEX-1 by p53, c-Myc, and multiple NF-κB/rel complexes. Oncogene 21, 6819–6828 (2002). https://doi.org/10.1038/sj.onc.1205854

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1205854

Keywords

This article is cited by

Search

Quick links